CANNABIS STRAINS

NTI secures strategic Cultivation partnership to grow and maintain its medical cannabis

Finfeed Archived Mar 09, 2021

Neurotech International Limited (ASX: NTI) has announced a strategic cultivation partnership with CannaPacific Limited to grow and maintain genetic stock and assist in the development of elite varietal strains through their exclusive licencing agreement.

Neurotech’s key near-term objectives

Finfeed Archived Jan 21, 2021

Neurotech International Limited (ASX: NTI) has provided a comprehensive overview and update regarding the company’s cannabis strains, development strategy and some of the key near-term objectives expected to be delivered.

NTI Days Away from Crucial Lab Results – Can its Cannabis Strain Treat Autism?

Catalyst Hunter Archived Dec 16, 2020

Neurotech International Ltd (ASX: NTI) is focused on the clinical applications of unique cannabis strains to treat neurological disorders such as autism and is set to commence human clinical trials early in 2021.

Cannabis Strains

NTI secures strategic Cultivation partnership to grow and maintain its medical cannabis

Neurotech’s key near-term objectives

NTI Days Away from Crucial Lab Results – Can its Cannabis Strain Treat Autism?